Find Reports
Select Report Type
Reimbursement Review
Displaying 576 - 600 of 1429
Please scroll or swipe to view the full content.
| Title | Brand Name | Generic Name | Files | Therapeutic Area | Recommendation Type | Status | Submission Date | Recommendation Date Sort ascending | Project Number |
|---|---|---|---|---|---|---|---|---|---|
| Tafinlar & Mekinist in com...Opens in new tab | Tafinlar & Mekinist in combo | Dabrafenib & Trametinib in combo | Non-Small Cell Lung Cancer | Do not reimburse | Complete | PC0106-000 | |||
| travoprost ophthalmic solutionOpens in new tab | Izba | travoprost ophthalmic solution | Glaucoma and ocular hypertension | Reimburse with clinical criteria and/or conditions | Complete | SR0516-000 | |||
| abobotulinumtoxinAOpens in new tab | Dysport Therapeutic | abobotulinumtoxinA | Upper limb spasticity | Reimburse with clinical criteria and/or conditions | Complete | SR0517-000 | |||
| Darzalex for Multiple Myeloma ...Opens in new tab | Darzalex | Daratumumab | Multiple Myeloma (second-line) | Reimburse with clinical criteria and/or conditions | Complete | PC0104-000 | |||
| Lynparza for Ovarian Cancer (R...Opens in new tab | Lynparza (Resubmission) | Olaparib | Ovarian Cancer | Reimburse with clinical criteria and/or conditions | Complete | PC0103-000 | |||
| Blincyto for Acute Lymphoblast...Opens in new tab | Blincyto (Resubmission) | Blinatumomab | Acute Lymphoblastic Leukemia (ALL) | Reimburse with clinical criteria and/or conditions | Complete | PC0097-000 | |||
| Rituxan for Acute Lymphoblasti...Opens in new tab | Rituxan | Rituximab | Acute Lymphoblastic Leukemia | Do not reimburse | Complete | PC0102-000 | |||
| Opdivo for Squamous Cell Carci...Opens in new tab | Opdivo | Nivolumab | Squamous Cell Carcinoma of Head and Neck (SCCHN) | Reimburse with clinical criteria and/or conditions | Complete | PC0095-000 | |||
| Keytruda for Advanced Non-Smal...Opens in new tab | Keytruda | Pembrolizumab | Advanced non-small cell lung carcinoma (first line) | Reimburse with clinical criteria and/or conditions | Complete | PC0101-000 | |||
| Blinatumomab (Blincyto) for Ac...Opens in new tab | Blincyto | Blinatumomab | Acute Lymphoblastic Leukemia (pediatric) | Reimburse with clinical criteria and/or conditions | Complete | PC0099 -000 | |||
| EliglustatOpens in new tab | Cerdelga | Eliglustat | Gaucher disease | Reimburse with clinical criteria and/or conditions | Complete | SR0511-000 | |||
| abobotulinumtoxinAOpens in new tab | Dysport Therapeutic | abobotulinumtoxinA | Cervical dystonia | Reimburse with clinical criteria and/or conditions | Complete | SR0512-000 | |||
| Glatiramer acetateOpens in new tab | Glatect | Glatiramer acetate | Relapsing Remitting Multiple Sclerosis (RRMS) | Reimburse with clinical criteria and/or conditions | Complete | SE0510-000 | |||
| EtanerceptOpens in new tab | Erelzi | Etanercept | Rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis | Reimburse with clinical criteria and/or conditions | Complete | SE0513-000 | |||
| Obeticholic AcidOpens in new tab | Ocaliva | Obeticholic Acid | Primary Biliary Cholangitis | Reimburse with clinical criteria and/or conditions | Complete | SR0509-000 | |||
| Ninlaro for Multiple Myeloma –...Opens in new tab | Ninlaro | Ixazomib | Multiple Myeloma | Do not reimburse | Complete | PC0088-000 | |||
| Daclizumab betaOpens in new tab | Zinbryta | Daclizumab beta | Multiple Sclerosis, relapsing-remitting | Reimburse with clinical criteria and/or conditions | Complete | SR0508-000 | |||
| Gazyva for Follicular Lymphoma...Opens in new tab | Gazyva | Obinutuzumab | Follicular Lymphoma | Reimburse with clinical criteria and/or conditions | Complete | PC0091-000 | |||
| EdoxabanOpens in new tab | Lixiana VTE | Edoxaban | Venous thromboembolism, treatment and recurrence prevention. | Reimburse with clinical criteria and/or conditions | Complete | SR0499-000 | |||
| emtricitabine/rilpivirine/ ten...Opens in new tab | Odefsey | emtricitabine/rilpivirine/ tenofovir alafenamide | HIV-1 infection | Reimburse with clinical criteria and/or conditions | Complete | SR0507-000 | |||
| IvabradineOpens in new tab | Lancora | Ivabradine | Heart failure, NYHA class II or III | Reimburse with clinical criteria and/or conditions | Complete | SR0506-000 | |||
| Tagrisso for Non-Small Cell Lu...Opens in new tab | Tagrisso | Osimertinib | Non-Small Cell Lung Cancer | Reimburse with clinical criteria and/or conditions | Complete | PC0076-000 | |||
| Alecensaro for Non-Small Cell ...Opens in new tab | Alecensaro | Alectinib | Non-Small Cell Lung Cancer | Do not reimburse | Complete | PC0092-000 | |||
| Propiverine hydrochlorideOpens in new tab | Mictoryl | Propiverine hydrochloride | Overactive bladder (OAB) | Reimburse with clinical criteria and/or conditions | Complete | SR0504-000 | |||
| SarilumabOpens in new tab | Kevzara | sarilumab | Arthritis, Rheumatoid | Reimburse with clinical criteria and/or conditions | Complete | SR0503-000 |
Health Technology Review
Displaying 576 - 600 of 602
Please scroll or swipe to view the full content.
Horizon Scan
Displaying 101 - 110 of 110
Projects in Progress
Displaying 26 - 26 of 26
View All Reports
Displaying 576 - 600 of 2141
Please scroll or swipe to view the full content.
| Title | Description | Files | Last Updated Sort ascending | Project Line | Project Sub Line | Status | Project Number |
|---|---|---|---|---|---|---|---|
| Somatropin for Short StatureOpens in new tab | Health Technology Review | Rapid Review | Completed | RC1501-000 | |||
| trastuzumab deruxtecanOpens in new tab | Reimbursement Review | Complete | PC0305-000 | ||||
| Remdesivir (Veklury) for the Treatment of COVID-19 in the Inpatient SettingOpens in new tab | Health Technology Review | Systematic Review | Completed | RE0048-000 | |||
| Tocilizumab (Actemra) for the Treatment of Hospitalized Patients With COVID-19Opens in new tab | Health Technology Review | Systematic Review | Completed | RE0049-000 | |||
| Nirmatrelvir-Ritonavir (Paxlovid) for the Treatment of COVID-19Opens in new tab | Health Technology Review | Health Technology Assessment | Completed | HT0042-000 | |||
| Remdesivir (Veklury) for the Treatment of COVID-19 in the Outpatient SettingOpens in new tab | Health Technology Review | Health Technology Assessment | Completed | HT0041-000 | |||
| abiraterone acetate and prednisoloneOpens in new tab | Reimbursement Review | Complete | PX0291-000 - PC0291-000 | ||||
| dapagliflozinOpens in new tab | Reimbursement Review | Complete | SX0749-000 - SR0749-000 | ||||
| abiraterone, prednisone, docetaxelOpens in new tab | Reimbursement Review | Complete | PX0298-000 - PC0298-000 | ||||
| Timing of Ventilator Circuit Tubing ReplacementOpens in new tab | Health Technology Review | Rapid Review | Completed | RC1498-000 | |||
| Telephone Triage ServicesOpens in new tab | Telephone triage programs provide timely access to trained health care professionals who can assess a patient’s symptoms over the phone and provide self-care advice or referral to an appropriate level of care. | Health Technology Review | Environmental Scan | Completed | ES0378-000 | ||
| Prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer (mCRPC)Opens in new tab | Health Technology Review | Technology Review | Completed | HC0060-000 | |||
| vericiguatOpens in new tab | Reimbursement Review | Complete | SR0758-000 | ||||
| atogepantOpens in new tab | Reimbursement Review | Complete | SR0724-000 | ||||
| upadacitinibOpens in new tab | Reimbursement Review | Complete | SR0759-000 | ||||
| Issues in Pediatric Health CareOpens in new tab | Shortage events, the phenomena when demand exceeds supply, can affect both medical care and medical devices. The COVID-19 pandemic caused a global shortage event, the consequences of which are still being experienced beyond the peak of the pandemic (e.g., the lack of pediatric pain medication available in fall 2022). | Horizon Scan | Emerging Health Technologies | Completed | EH0116-000 | ||
| Transcatheter Edge-To-Edge Valve Repair for Tricuspid RegurgitationOpens in new tab | Health Technology Review | Rapid Review | Completed | RC1500-000 | |||
| Artificial Intelligence in Prehospital Emergency Health CareOpens in new tab | Health care systems in Canada, including prehospital emergency health care services, are facing staffing shortages and increased patient volumes, and are looking for creative solutions to ensure the provision of high-quality care. | Horizon Scan | Health Technology Update | Completed | EN0052-000 | ||
| Utilization of Opioid Agonist Therapies in CanadaOpens in new tab | Health Technology Review | Technology Review | Completed | HC0064-000 | |||
| cariprazineOpens in new tab |
Memorandum report to CADTHOpens in new tabResponse to the Procedural Review Panel’s Memorandum Report on the Procedural R…Opens in new tabRecommendation and ReasonsOpens in new tabClinical and Pharmacoeconomic combined ReportOpens in new tabStakeholder feedback on Draft RecommendationOpens in new tab |
Reimbursement Review | Complete | SR0708-000 | |||
| Non-Small Cell Lung Cancer without actionable oncogenic alterationsOpens in new tab | Reimbursement Review | Provisional Funding Algorithm | Complete | PH0029-000 | |||
| Lipid Panel Screening for Adults Living With Chronic ConditionsOpens in new tab | Health Technology Review | Rapid Review | Completed | RC1497-000 | |||
| Cost-Effectiveness of an RSVpreF Vaccine for Prevention of Respiratory Syncytial Virus Outcomes in InfantsOpens in new tab | Health Technology Review | Technology Review | Complete | HE0044-000 | |||
| Somatropin for Turner SyndromeOpens in new tab | Health Technology Review | Rapid Review | Completed | RC1493-000 | |||
| Somatropin for Growth Hormone Deficiency Opens in new tab | Health Technology Review | Rapid Review | Completed | RC1492-000 |
Provisional Funding Algorithm
Displaying 76 - 81 of 81